Literature DB >> 1539717

Influence of subendocardial ischemia on transmural myocardial function.

N C Edwards1, A J Sinusas, J D Bergin, D D Watson, M Ruiz, G A Beller.   

Abstract

The relationship between regional myocardial perfusion and function under ischemic conditions was examined by using a nontraumatic single-crystal pulsed Doppler system that permits complete transmural assessment of myocardial thickening. Sixteen open-chest dogs underwent either 50 (n = 4) or 180 (n = 12) min of partial coronary artery occlusion. Simultaneous measurements of myocardial thickening fraction (TF) and microsphere-determined blood flow (BF) were taken in the subepicardial, midwall, and subendocardial thirds of the left ventricular wall. During ischemia, there was an excellent correlation between BF and TF in the subendocardium. Mean subendocardial BF was reduced to 0.45 +/- 0.3 ml.min-1.g-1, resulting in a subendocardial TF of 0.8 +/- 19%. Although subepicardial BF was relatively preserved at 1.03 +/- 0.4 ml.min-1.g-1, subepicardial TF was diminished markedly and not significantly different from subendocardial TF. Subepicardial and midwall TF were highly dependent on subendocardial flow rather than on the actual flow in these areas. Hence these studies show a marked dependence of transmural myocardial function on subendocardial blood flow. Outer wall function is more dependent on subendocardial than subepicardial blood flow.

Entities:  

Mesh:

Year:  1992        PMID: 1539717     DOI: 10.1152/ajpheart.1992.262.2.H568

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

Review 1.  Regional myocardial mechanics: integrative computational models of flow-function relations.

Authors:  A D McCulloch; R Mazhari
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

Review 2.  Evolving therapeutic concepts and imaging in ischemic cardiomyopathy.

Authors:  A Lahiri; R Senior
Journal:  J Nucl Cardiol       Date:  1998 Nov-Dec       Impact factor: 5.952

3.  Metabolic imaging: what are the challenges?

Authors:  L H Young; P H McNulty
Journal:  J Nucl Cardiol       Date:  1994 Mar-Apr       Impact factor: 5.952

Review 4.  Experimental evaluation of radiotracers: role of intact biological models.

Authors:  A J Sinusas
Journal:  J Nucl Cardiol       Date:  1998 Mar-Apr       Impact factor: 5.952

5.  Acute ischemic dysfunction alters coronary flow reserve in remote nonischemic regions: potential mechanical etiology identified in an acute canine model.

Authors:  E Daher; D P Dione; E N Heller; J Holahan; P DeMan; M Shen; J Hu; A J Sinusas
Journal:  J Nucl Cardiol       Date:  2000 Mar-Apr       Impact factor: 5.952

6.  Severe regional ischemia alters coronary flow reserve in the remote perfusion area.

Authors:  J C Wu; J J Yun; D P Dione; E N Heller; L I Deckelbaum; A J Sinusas
Journal:  J Nucl Cardiol       Date:  2000 Jan-Feb       Impact factor: 5.952

Review 7.  Chronic ischemic left ventricular dysfunction: from pathophysiology to imaging and its integration into clinical practice.

Authors:  Shahbudin H Rahimtoola; Vasken Dilsizian; Christopher M Kramer; Thomas H Marwick; Jean-Louis J Vanoverschelde
Journal:  JACC Cardiovasc Imaging       Date:  2008-07

8.  Biphasic response to dobutamine predicts improvement of left ventricular dysfunction after revascularization: correlation with positron emission and rest-redistribution 201Tl tomographies.

Authors:  M Hernandez-Pampaloni; V Peral; J L Carreras; L Sanchez-Harguindey; I Vilacosta
Journal:  Int J Cardiovasc Imaging       Date:  2003-12       Impact factor: 2.357

9.  Regional myocardial strain analysis via 2D speckle tracking echocardiography: validation with sonomicrometry and correlation with regional blood flow in the presence of graded coronary stenoses and dobutamine stress.

Authors:  John C Stendahl; Nripesh Parajuli; Allen Lu; Nabil E Boutagy; Nicole Guerrera; Imran Alkhalil; Ben A Lin; Lawrence H Staib; Matthew O'Donnell; James S Duncan; Albert J Sinusas
Journal:  Cardiovasc Ultrasound       Date:  2020-01-15       Impact factor: 2.062

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.